s The only effective agents against advanced and metastatic prostate cancer are hormonal and antitubulin cytotoxic drugs Androgen blocking agents ZYTIGA (abiraterone) and XIANG' (enzolutomide) have significant cross resistance Men who progress on these agents are being healed with antilubulin chemo